"We are a subsidiary of Natcopharma Limited, we sell affordable medicines that meet global standards and strive to achieve a prominent position in the Brazilian market."

NATCO GLOBAL

Currently, the Natco family is made up of approximately 5,000 employees. We are constantly ranked among the fastest growing pharmaceutical companies in India. Natco is well recognized for its innovation in pharmaceutical research and development.

www.natcopharma.co.in

natcofarma1
Play Video

institutional video

NATCO PHARMA LIMITED

NATCO PHARMA LIMITED is a pharmaceutical company founded 40 years ago and is present in almost every continent.

investments

7.8% of Global Revenue is Invested in R&D Annually

+ 1
Approved Patents
1
Factories World
1
Research Center

everolimo

1st Generic in Brazil!

Antineoplastic, for the treatment of advanced breast cancer, advanced neuroendocrine tumors, renal and treatment of subependymal giant cell astrocytoma.

EVEROLIMO in addition to Brazil, is already commercialized in Europe, USA and Canada.

articles

natco news

Stay on top of the main news and trends in the pharmaceutical industry!

service channels

Contact

Contact us in one of our service channels.

SAC

0800-0303043
Seg - Sex - 09:00 ás 17:00 h

E-MAIL

sac@natcofarma.com

Rio de Janeiro - Brasil

Estrada dos Três Rios, nº 958, sala 313 a 330, Freguesia
Rio de Janeiro - RJ - CEP 22.745-005
Tel.: (21) 3559-6900

Scroll Up